Angiopoietin-2 (Ang-2) is highly upregulated during pathological angiogenesis and antagonizes the actions of Ang-1, as such allowing new vessels to sprout. Using the limb ischemic model we recently showed that Ang-2 dosage is important. However, the molecular mechanisms of Ang-2-mediated neovessel formation has only been started to be analyzed. Therefore, within the next funding period of the SFB/TR23 we plan to decipher in detail the in vivo functions of Ang-2 on endothelial integrity and the recruitment of accessory cells during tumor angiogenesis using a transgenic mouse model with inducible endothelial-specific Angiopoietin-2 expression. |